Assessment of 21-[18F]fluoro-16α-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas
F. Dehdashti, A. H. McGuire, H. F. Van Brocklin, B. A. Siegel, D. P. Andriole, L. K. Griffeth, M. G. Pomper, J. A. Katzenellenbogen, M. J. Welch
Dive into the research topics of 'Assessment of 21-[18F]fluoro-16α-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas'. Together they form a unique fingerprint.